Why the study?
Does long-term metoprolol therapy improve clinical outcomes, cardiac function, and survival in patients with dilated cardiomyopathy?
Does long-term metoprolol therapy improve clinical outcomes, cardiac function, and survival in patients with dilated cardiomyopathy?
Long-term metoprolol therapy in patients with dilated cardiomyopathy improves NYHA functional class, left ventricular function, ventricular arrhythmias, and survival.
No takes yet. Share an insight, caveat, or question.
Metoprolol was associated with better survival in DCM; leaves open whether RCTs will confirm benefit before practice change.
YOKOTA et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: